Health
AMS BioteQ Makes Debut at Medical Japan 2023: Bringing Innovative Healthcare into New Horizons
TAIPEI, Oct. 25, 2023 /PRNewswire/ -- Medical Japan Tokyo was held grandly from October 11 to 13, gathering medical professionals, manufacturers, medical institutions, and research units from around the world. AMS BioteQ Co., Ltd. made its first appearance in the exhibition and became one of the ...
2023-10-25 13:06
1763
Snapdragon Chemistry, a Cambrex Company, Recognized with CPhI Pharma Award for API Development
EAST RUTHERFORD, N.J, Oct. 25, 2023 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced that Snapdragon Chemistry has been selected as the winner of the API Development Award, presented at the CPhI Pharma Awards inBarcelona, Spain....
2023-10-25 04:18
2019
Cyrus K. Mirsaidi Named Global CEO to Bridgewest Perth Pharma
--Industry veteran to lead growth for company's CDMO and pharmaceutical supply divisions, NovaCina and LumaCina-- MIAMI and PERTH, Australia, Oct. 25, 2023 /PRNewswire/ -- Bridgewest Perth Pharma, a global pharmaceutical supply and manufacturing company, announced today thatCyrus K. Mirsaidi is ...
2023-10-24 23:17
1555
Wolters Kluwer Applauded by Frost & Sullivan for Improving Healthcare Efficiencies, Quality, and Outcomes and for Its Competitive Strategies
Wolters Kluwer uniquely leverages its expertise to meet market and customer needs, positioning it to capitalize on new growth opportunities and lead in healthcare conversational AI. SAN ANTONIO, Oct. 24, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the conversational artificial inte...
2023-10-24 21:30
1459
OrbiMed Raises $4.3 Billion Across Private Investment Funds
NEW YORK, Oct. 24, 2023 /PRNewswire/ -- OrbiMed, a global healthcare investment firm, is pleased to announce it has raised more than$4.3 billion in commitments for its latest private investment funds, including OrbiMed Private Investments IX, OrbiMed Asia Partners V and OrbiMed Royalty & Credit O...
2023-10-24 19:30
1765
Life Molecular Imaging and Sinotau Pharmaceutical Group Announce the Regulatory Approval of their Amyloid PET Imaging Radiopharmaceutical Neuraceq® in China
First Amyloid PET Tracer Received Regulatory Approval in China BERLIN and BEIJING, Oct. 24, 2023 /PRNewswire/ -- Life Molecular Imaging (LMI) and Sinotau Pharmaceutical Group are pleased to announce Neuraceq® (with Chinese trade name 欧韦宁®, florbetaben F-18 injection) has received regulatory appr...
2023-10-24 16:00
1533
SID BIO Inc. to Debut at 'in-cosmetics asia 2023,' the World's Largest Cosmetics Ingredients Expo
SEOUL, South Korea, Oct. 24, 2023 /PRNewswire/ -- Korean K-beauty specialist company SID BIO Inc. will make its global market debut at 'in-cosmetics asia 2023,' the world's largest cosmetics ingredients expo, taking place from November 7-9 at the Bangkok International Trade & Exhibition Centre (BI...
2023-10-24 15:50
1461
BioWorld by Clarivate Examines Impact of Emerging Medicines on Obesity
Three-part, in-depth analysis of biopharma investments in obesity medications highlights potential impact onpatient population historically faced with limited options LONDON, Oct. 24, 2023 /PRNewswire/ -- BioWorld™ published by Clarivate Plc (NYSE:CLVT), a global leader in connecting people and ...
2023-10-24 15:00
1432
Recbio appeared at the 14th China (Taizhou) International Pharmaceutical Fair
TAIZHOU, China, Oct. 24, 2023 /PRNewswire/ -- From October 19 to 22, the 14th China (Taizhou) International Pharmaceutical Fair, sponsored by the China Chamber of International Commerce and hosted by the Taizhou Municipal People's Government andJiangsu Branch of the China Council for the Promotio...
2023-10-24 13:39
2107
Cellomics announces Mr. Andy A. Liu as new Group CEO of the Company
Hong Kong, Oct. 24, 2023 /PRNewswire/ -- Cellomics, the leader in liquid biopsy technology for cancer screening and precision diagnosis, is pleased to announce the appointment of Mr.Andy A. Liu as the new Group CEO of the company. With over 25 years of healthcare experience, Mr. Liu brings a weal...
2023-10-24 12:00
2473
Singapore-based Juniper Biologics Awarded the Most Innovative Oncology Pharmaceutical Company 2023 by GHP Healthcare and Pharmaceutical Awards
SINGAPORE, Oct. 24, 2023 /PRNewswire/ -- Juniper Biologics
2023-10-24 12:00
1519
CCTV+: Jianchangbang Pharmacy: A Thousand Years of Tradition and Excellence
BEIJING, Oct. 24, 2023 /PRNewswire/ -- As a living legacy of Jiangxi's rich culture of traditional Chinese medicine (TCM), the respected brand, Jianchangbang Pharmacy, carries forward the splendor of Chinese medical wisdom. It is a renowned sect of theSouth China ancient TCM school and TCM prepar...
2023-10-24 11:51
1795
Based on recent data presented at 2023 ESMO, the innovative TROP2 ADC SKB264 (MK-2870) shows promising prospects for the treatment of patients with HR+/HER2- metastatic breast cancer who have undergone multiple prior lines of therapy , and its clinical development in other solid tumors is also advancing steadily
CHENGDU, China, Oct. 24, 2023 /PRNewswire/ -- Human trophoblastic cell surface antigen 2 (TROP2) exhibits high expression in numerous solid tumors, making it a prominent target in recent oncology studies. The progress in the development of Antibody-Drug Conjugates (ADCs) against this target has ...
2023-10-24 10:19
2535
Council of ASEAN Chief Justices reflect milestones and achievements over the past 10 years, and chart strategic agenda
SINGAPORE, Oct. 24, 2023 /PRNewswire/ -- The Council of ASEAN Chief Justices (CACJ) held its inaugural retreat on 20 October to reaffirm the ASEAN Judiciaries' strategic and cohesive approach towards deepening judicial cooperation and upholding the Rule of Law. It was hosted by the Malaysian Jud...
2023-10-24 10:07
1587
Alphamab Oncology Announces New Data from Multiple Studies of KN046 with Lung Cancer and Thymic Carcinoma at ESMO
* KN046 showed encouraging efficacy result especially in OS benefit (mOS: 20.2 months) in advanced NSCLC with EGFR sensitivity mutation who progressed after EGFR-TKI(s). * KN046 showed encouraging efficacy result especially in OS benefit (mOS: 13.3months) in advanced NSCLC with EGFR sensitivi...
2023-10-24 08:41
1597
Alphamab Oncology updated data from two studies of KN026 in combination with docetaxel for HER2-positive breast cancer at ESMO
* KN026 combined with docetaxel has significant efficacy in the first-line treatment of HER2-positive recurrent or metastatic breast cancer, with mPFS of 26.9 months and 24-month OS rate of 84.2%. * KN026 combined with docetaxel has significant efficacy and good tolerability in the neoadjuvan...
2023-10-24 08:41
3248
LifeSpan Vision Ventures Invests in Matter Bio
NORWALK, Conn., Oct. 24, 2023 /PRNewswire/ -- LifeSpan Vision Ventures today announced an investment in Matter Bio, a longevity holding company focused on preserving genome integrity. Central to the company's philosophy is that as we age, our genome is constantly being damaged by exogenous and en...
2023-10-24 03:40
1945
LBB Specialties Announces Principal Partnership with Viscofan
NORWALK, Conn., Oct. 23, 2023 /PRNewswire/ -- LBB Specialties (LBBS), a leader inspecialty chemicals and ingredients distribution in North America, announces a new partnership with Viscofan DE, a global leader in collagen manufacturing. LBB Specialties will be Viscofan's preferred partner inthe U...
2023-10-23 23:00
1604
XINGIMAGING and MITRO BIOTECH CO., LTD. MERGE TO DELIVER FULL-SERVICE CRO OPERATIONS TO GLOBAL RESEARCH INITIATIVES
NEW HAVEN, Conn., Oct. 23, 2023 /PRNewswire/ -- XINGIMAGING, LLC, and MITRO Biotech Co., Ltd., two recognized lead companies offering quality and excellence in drug development and imaging solutions, have merged to create one company dedicated to providing a full spectrum of CRO & CDMO research s...
2023-10-23 22:38
1644
Transcenta Unveils Updated Efficacy Data from Osemitamab (TST001) Plus CAPOX as First-Line Treatment for G/GEJ Cancer Study at ESMO 2023
Latest data reveals a 55% confirmed response rate, median duration of response (DoR) and median progression-free survival (PFS) of more than 12 months for all patients treated in the expansion cohort PRINCETON, N.J. and SUZHOU, China, Oct. 23, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Tr...
2023-10-23 21:48
3977
Week's Top Stories
Most Reposted
QDX Co-Founder Giuseppe Barca Awarded Prestigious Gordon Bell Prize, Pioneering Advancements in Drug Discovery Technology
[Picked up by 303 media titles]
2024-11-26 18:49ITAP 2024 sets the stage for a more connected advanced factory ecosystem with focus on AI, advanced robotics and sustainability
[Picked up by 297 media titles]
2024-11-28 17:24Southeast Asian Consumers Raise Online Security Concerns, New GSMA Survey Shows
[Picked up by 296 media titles]
2024-11-26 13:00MediSun Energy Raises $8.75M Seed Round with Vynn Capital to Drive MENA Expansion and Advance Osmotic Energy Innovation
[Picked up by 280 media titles]
2024-11-25 10:00
Mentech at COP29: Showing the Eco-friendly Lifestyle with Technological Innovation
[Picked up by 278 media titles]
2024-11-29 20:33
Most Read
Mentech at COP29: Showing the Eco-friendly Lifestyle with Technological Innovation
2024-11-29 20:33
6075
Southeast Asian Consumers Raise Online Security Concerns, New GSMA Survey Shows
2024-11-26 13:00
5154